GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » 5-Year Yield-on-Cost %
中文

Indo-Bangla Pharmaceuticals (DHA:IBP) 5-Year Yield-on-Cost % : 0.53 (As of Apr. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals 5-Year Yield-on-Cost %?

Indo-Bangla Pharmaceuticals's yield on cost for the quarter that ended in . 20 was 0.53.


The historical rank and industry rank for Indo-Bangla Pharmaceuticals's 5-Year Yield-on-Cost % or its related term are showing as below:

DHA:IBP' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 3
Current: 0.53


During the past 0 years, Indo-Bangla Pharmaceuticals's highest Yield on Cost was 3.00. The lowest was 0.00. And the median was 0.00.


DHA:IBP's 5-Year Yield-on-Cost % is ranked worse than
88.38% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs DHA:IBP: 0.53

Competitive Comparison of Indo-Bangla Pharmaceuticals's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Indo-Bangla Pharmaceuticals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo-Bangla Pharmaceuticals's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo-Bangla Pharmaceuticals's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Indo-Bangla Pharmaceuticals's 5-Year Yield-on-Cost % falls into.



Indo-Bangla Pharmaceuticals 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Indo-Bangla Pharmaceuticals is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Indo-Bangla Pharmaceuticals  (DHA:IBP) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Indo-Bangla Pharmaceuticals 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo-Bangla Pharmaceuticals (DHA:IBP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Plot No. 183, 6th Floor, Block B, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in manufacturing, marketing and distribution of generic pharmaceuticals products which includes human drugs dosages form such as tablet, capsule, syrup, oral saline, suspension. The products of the company are sold in domestic market. The company has also applied for permission for production and selling of veterinary medicine.